Recent News

• 02.23.2026 - 8-K - Current report
• 02.23.2026 - Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
• 02.23.2026 - Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
• 02.17.2026 - SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors
• 01.06.2026 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
• 01.06.2026 - 4 - Statement of changes in beneficial ownership of securities
• 12.31.2025 - 8-K - Current report
• 12.17.2025 - EFFECT - Notice of Effectiveness
• 12.15.2025 - POS AM - Post-effective amendment to a registration statement that is not immediately effective upon filing
• 12.15.2025 - RW - Registration Withdrawal Request

Recent Filings

• 02.23.2026 - 8-K Current report
• 02.23.2026 - EX-99.1 EX-99.1
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.06.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 12.31.2025 - 8-K Current report
• 12.16.2025 - EFFECT Notice of Effectiveness
• 12.15.2025 - RW Registration Withdrawal Request
• 12.15.2025 - POS AM Post-Effective amendments for registration statement